Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases ...

The patient succumbed to the deadly virus at a private hospital in Perinthalmanna. His test results returned Nipah positive ...

Recent double-blind, randomized, controlled trials reported that human umbilical cord-derived mesenchymal stem cell (MSC) infusions in COVID-19 patients with acute respiratory distress syndrome ...

Kerala, which first reported Nipah outbreak in 2018, has recorded four cases this year so far, of which two have died, one recovered and the other is undergoing treatment.

Three De-suup trainees, a man and two women, have died at the national referral hospital after a Leptospirosis outbreak at a ...

The global sepsis diagnostics market size was US$ 570 million in 2021. The global sepsis diagnostics market size is forecast to reach US$ 1,111.26 million by 2030, growing at a compound annual growth ...

Surveillance and medical protocols are in place, but environmental factors for the epidemic reappearing regularly cannot be ruled out.

Bonus Biogroup (TASE: BONS), a late-stage biotechnology company priming immunomodulatory and regenerative mesenchymal stem cells (MSC) to develop novel tissue engineering and cell therapy solutions, ...

A previously healthy people may develop myocarditis (inflammation of the heart tissue), pneumonia, acute respiratory distress syndrome (ARDS), and in certain situations, multi-organ dysfunction.

Measurements The primary outcome measure was a composite endpoint of the incidence of acute respiratory distress syndrome, postoperative pulmonary ... of surgery or hospital discharge if earlier (3) ...

Objective To determine the incidence of acute respiratory illness (ARill) in athletes and by method of diagnosis, anatomical classification, ages, levels of performance and seasons. Design Systematic ...